HeartSciences (HSCS) Competitors $3.30 +0.29 (+9.63%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$3.40 +0.11 (+3.18%) As of 04:48 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. STRR, VVOS, COCH, ICU, RVP, NRXS, PETV, IRIX, DRIO, and NXGLShould you be buying HeartSciences stock or one of its competitors? The main competitors of HeartSciences include Hudson Global (STRR), Vivos Therapeutics (VVOS), Envoy Medical (COCH), SeaStar Medical (ICU), Retractable Technologies (RVP), NeurAxis (NRXS), PetVivo (PETV), IRIDEX (IRIX), DarioHealth (DRIO), and NexGel (NXGL). These companies are all part of the "medical equipment" industry. HeartSciences vs. Its Competitors Hudson Global Vivos Therapeutics Envoy Medical SeaStar Medical Retractable Technologies NeurAxis PetVivo IRIDEX DarioHealth NexGel Star Equity (NASDAQ:STRR) and HeartSciences (NASDAQ:HSCS) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment. Does the media prefer STRR or HSCS? In the previous week, HeartSciences had 1 more articles in the media than Star Equity. MarketBeat recorded 4 mentions for HeartSciences and 3 mentions for Star Equity. HeartSciences' average media sentiment score of 0.98 beat Star Equity's score of 0.12 indicating that HeartSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Star Equity 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is STRR or HSCS more profitable? HeartSciences has a net margin of 0.00% compared to Star Equity's net margin of -2.81%. Star Equity's return on equity of -3.81% beat HeartSciences' return on equity.Company Net Margins Return on Equity Return on Assets Star Equity-2.81% -3.81% -2.84% HeartSciences N/A -383.38%-145.28% Which has stronger valuation and earnings, STRR or HSCS? Star Equity has higher revenue and earnings than HeartSciences. Star Equity is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStar Equity$140.06M0.19-$4.77M-$1.30-7.55HeartSciencesN/AN/A-$8.77M-$8.30-0.40 Do analysts rate STRR or HSCS? Star Equity presently has a consensus target price of $5.00, suggesting a potential downside of 49.03%. HeartSciences has a consensus target price of $13.00, suggesting a potential upside of 293.94%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts clearly believe HeartSciences is more favorable than Star Equity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Star Equity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00HeartSciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of STRR or HSCS? 3.8% of Star Equity shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 10.4% of Star Equity shares are owned by insiders. Comparatively, 1.8% of HeartSciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk & volatility, STRR or HSCS? Star Equity has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500. Comparatively, HeartSciences has a beta of 2.56, suggesting that its stock price is 156% more volatile than the S&P 500. SummaryHeartSciences beats Star Equity on 9 of the 15 factors compared between the two stocks. Get HeartSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeartSciencesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.96M$2.16B$5.80B$10.16BDividend YieldN/AN/A5.72%4.60%P/E Ratio-0.4035.4275.1326.39Price / SalesN/A10.19508.32174.86Price / CashN/A58.5825.8129.91Price / Book18.3311.5813.716.28Net Income-$8.77M-$63.67M$3.29B$270.38M7 Day Performance-2.94%-1.82%0.07%1.89%1 Month Performance-2.37%1.84%4.57%6.01%1 Year Performance13.79%36.11%78.24%25.26% HeartSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeartSciences2.9003 of 5 stars$3.30+9.6%$13.00+293.9%+8.6%$7.96MN/A-0.4010Earnings ReportGap UpSTRRHudson Global0.5968 of 5 stars$9.27-3.7%$5.00-46.1%+138.1%$29.99M$137.86M-7.131,300High Trading VolumeVVOSVivos Therapeutics2.828 of 5 stars$3.87+1.0%$4.92+27.0%+14.6%$29.03M$15.03M-2.30160Short Interest ↓COCHEnvoy Medical2.0995 of 5 stars$1.28-2.3%$9.25+622.7%-59.3%$27.55M$220K-0.9034ICUSeaStar Medical0.3877 of 5 stars$0.88+4.6%N/A-82.8%$24.44M$140K-0.332Short Interest ↑RVPRetractable Technologies1.0594 of 5 stars$0.81+1.6%N/A-9.9%$24.22M$38.16M-1.50240Short Interest ↑NRXSNeurAxis2.0673 of 5 stars$2.45+1.2%$7.00+185.7%-21.2%$24.19M$3.22M-1.3319News CoverageNegative NewsShort Interest ↑PETVPetVivoN/A$0.85+3.2%N/A+59.6%$23.72M$1.05M-1.8920News CoverageGap UpIRIXIRIDEX0.7076 of 5 stars$1.36-1.4%N/A-36.3%$23.11M$49.74M-4.12120DRIODarioHealth1.6159 of 5 stars$9.14-0.7%$40.00+337.6%-64.8%$20.79M$27.15M-0.69200NXGLNexGel0.8921 of 5 stars$2.34+5.4%N/A-5.5%$18.88M$8.69M-5.8510Gap Up Related Companies and Tools Related Companies Hudson Global Competitors Vivos Therapeutics Competitors Envoy Medical Competitors SeaStar Medical Competitors Retractable Technologies Competitors NeurAxis Competitors PetVivo Competitors IRIDEX Competitors DarioHealth Competitors NexGel Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartSciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSCS Stock Alerts